Soluble mediators of inflammation in HIV and their implications for therapeutics and vaccine development
about
Immunovirological parameters and cytokines in HIV infectionInnate and Adaptive Immune Regulation During Chronic Viral InfectionsAging of the human innate immune system in HIV infection.Tumor necrosis factor α is associated with viral control and early disease progression in patients with HIV type 1 infection.Replicative fitness of transmitted HIV-1 drives acute immune activation, proviral load in memory CD4+ T cells, and disease progressionHIV-1 Tat Protein Induces Production of Proinflammatory Cytokines by Human Dendritic Cells and Monocytes/Macrophages through Engagement of TLR4-MD2-CD14 Complex and Activation of NF-κB Pathway.Continuous Antigenic Stimulation of DO11.10 TCR Transgenic Mice in the Presence or Absence of IL-1β: Possible Implications for Mechanisms of T Cell Depletion in HIV DiseaseDistinct cytokine/chemokine network in semen and blood characterize different stages of HIV infectionMucosal immunology of HIV infection.Plasma monocyte chemoattractant protein-1 and tumor necrosis factor-α levels predict the presence of coronary artery calcium in HIV-infected individuals independent of traditional cardiovascular risk factors.Thymosin alpha 1 and HIV-1: recent advances and future perspectives.The effect of HIV infection and HCV viremia on inflammatory mediators and hepatic injury-The Women's Interagency HIV Study.Cytokines Elevated in HIV Elite Controllers Reduce HIV Replication In Vitro and Modulate HIV Restriction Factor Expression.HIV-1 Tat protein induces PD-L1 (B7-H1) expression on dendritic cells through tumor necrosis factor alpha- and toll-like receptor 4-mediated mechanisms.Soluble endothelial protein C receptor (sEPCR) as an inflammatory biomarker in naive HIV-infected patients during ART.
P2860
Q26829264-337A2B3B-2FEA-4A84-81B1-8C22B53D83A3Q28079717-66DEF70A-38F4-455C-890D-EA8A7BB1968BQ34094201-34455585-7B60-455B-8DE8-5C7A328E1FCAQ34430248-DE2D6089-AA42-400A-A973-3900AB452F08Q35229333-3D43A7AB-8AFC-4EC1-B522-4E086294AB79Q35668299-FD57D0E1-C0E6-432C-8A44-F54DDE66E057Q36177047-F5650019-56C2-4649-B427-79AFA8C7D076Q36888298-E2461F2C-A919-4946-A1DD-380F8B03C1FEQ36957775-3930FE57-F01B-4448-84E2-F291323FDC0FQ37543248-C81D2356-4A4C-442A-A6D9-26B6B7A7F34DQ38768132-8B8B0425-DD65-48E2-90DB-E417B12D1FA6Q40043487-C5B079F6-80CB-4F27-94A4-7C3D04E77B2CQ40385320-A21988C1-64F0-47A9-884B-652F043CE51CQ40606349-DDF1B69C-9D40-4626-90B1-276B232FBEF7Q40786980-8CF200C4-59DA-4DF3-A5E0-1501EF4014BA
P2860
Soluble mediators of inflammation in HIV and their implications for therapeutics and vaccine development
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Soluble mediators of inflammat ...... eutics and vaccine development
@ast
Soluble mediators of inflammat ...... eutics and vaccine development
@en
type
label
Soluble mediators of inflammat ...... eutics and vaccine development
@ast
Soluble mediators of inflammat ...... eutics and vaccine development
@en
prefLabel
Soluble mediators of inflammat ...... eutics and vaccine development
@ast
Soluble mediators of inflammat ...... eutics and vaccine development
@en
P2860
P1476
Soluble mediators of inflammat ...... eutics and vaccine development
@en
P2093
Evan S Jacobs
Philip J Norris
P2860
P304
P356
10.1016/J.CYTOGFR.2012.05.006
P577
2012-06-27T00:00:00Z